EUVIMEDAtrasti EUVIMED
EUVIMED · CrossrefJournal

Arthritis & Rheumatology

ISSN 2326-5191 · Wiley

Latest articles

  1. Sjögren's Disease Salivary Gland Fibroblast Subsets are Interferon Enriched and Aberrantly Promote Pain

    Sara S. McCoy, Rachael Bogle, Michele C. Larsen, Yuli Cai, John A. Chiorini, Thomas T.F. Pranzatelli, Alan N. Baer, Paola Perez, Margaret E. Beach, Zohreh Khavandgar, Eileen Pelayo, A. Darise Farris, Christopher J. Lessard, Caroline Shiboski, Changyu Zheng, Daniel Martin Izquierdo, Zachary T. Campbell, Lam C. Tsoi, Johann E. Gudjonsson, Blake M. Warner

    Published: 2026-11-20DOI: 10.1002/art.70396

  2. Initial Treatment Strategies and Outcomes Across Hemodynamic Thresholds and Risk Stratification in Incident Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A EUSTAR Analysis

    Hilde Jenssen Bjørkekjær, Cosimo Bruni, Kaspar Broch, Cathrine Brunborg, Patricia E. Carreira, Paolo Airò, Carmen Pilar Simeón‐Aznar, Marie‐Elise Truchetet, Alessandro Giollo, Alexandra Balbir‐Gurman, Mickael Martin, Christopher P. Denton, Armando Gabrielli, Francesco Del Galdo, Madelon C. Vonk, Håvard Fretheim, Helle Bitter, Øyvind Midtvedt, Arne K. Andreassen, Sverre Høie, Yoshiya Tanaka, Gabriela Riemekasten, Ulf Müller‐Ladner, Marco Matucci‐Cerinic, Ivan Castellví, Elise Siegert, Eric Hachulla, Øyvind Molberg, Oliver Distler, Anna‐Maria Hoffmann‐Vold

    Published: 2026-11-11DOI: 10.1002/art.70372

  3. Cluster analysis identifies anti‐synthetase syndrome as a distinct and heterogeneous clinical entity: Analysis from the Classification Criteria for Anti‐Synthetase Syndrome project database

    Akira Yoshida, Iazsmin Bauer Ventura, Eduardo Dourado, Giovanni Zanframundo, Sara Faghihi‐Kashani, Aravinthan Loganathan, Daphne Rivero Gallegos, Francisca Bozan, Gianluca Sambataro, Sangmee Sharon Bae, Laure Gallay, Albert Selva‐O'Callaghan, Andrew L. Mammen, Carlomaurizio Montecucco, Chester V. Oddis, David F. Fiorentino, Francesco Bonella, Frederick W. Miller, Ingrid E. Lundberg, Jorge Rojas‐Serrano, Masataka Kuwana, Miguel Angel González‐Gay, Neil McHugh, Tamera J. Corte, Tracy Jennifer Doyle, Vega Jovani, Linda Carli, Pier Paolo Sainaghi, Natsuka Umezawa, Merrilee Needham, Giovanni Cagnotto, Nair Perez‐Gómez, Paola Tomietto, Massimiliano Limonta, Maria Giovanna Danieli, Antonella Notarnicola, José Cifrian‐Martinez, Julia Martinez‐Barrio, Helena Andersson, Yasuhiro Kondoh

    Published: 2026-11-11DOI: 10.1002/art.70388

  4. Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic‐Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double‐Blind, Placebo‐Controlled APEX Study

    Christopher T. Ritchlin, Philip J. Mease, Laura C. Coates, Alexa P. Kollmeier, Bei Zhou, Yusang Jiang, Karen Bensley, Koeun Im, Rattandeep Batra, Karissa Lozenski, Soumya D. Chakravarty, Proton Rahman, Désirée van der Heijde

    Published: 2026-10-20DOI: 10.1002/art.70380

  5. Persistent Interleukin‐18 Fuels Expansion of CD38 + HLA ‐ DR + CD8 + T Cells in Still Disease and Macrophage Activation Syndrome

    Greta Rogani, Remco G. A. Erkens, Alejandra Bodelón, Tim R. Mocking, Marein T. M. Putmans, Freya M. C. H. Huijsmans, Lyanne J. P. M. Sijbers, Aafke M. De Ligt, Maurice J. H. Van Haaren, Rianne C. Scholman, Noël M. M. Dautzenberg, Joyce I. Meesters‐Ensing, Martina Rossano, Laura Porretti, Stefan Nierkens, Francesca S. Minoia, Sebastiaan J. Vastert, Jorg van Loosdregt

    Published: 2026-09-15DOI: 10.1002/art.70319

Volumes

2026 · 4932025 · 3802024 · 2922023 · 3502022 · 3682021 · 4152020 · 3742019 · 3552018 · 3482017 · 3922016 · 4612015 · 4872014 · 6822010 · 11997 · 111989 · 21

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.